We are pleased to announce that an early version of the Company’s potential world-first blood test for endometriosis has successfully detected up to 78 per cent of people with the painful condition. The results are being presented at the Fertility Society of Australia and New Zealand Annual Conference.
While the test’s diagnostic performance is promising, we expect it can be further developed to make it even more accurate. If successful, the outcome would be a clinically validated blood test(s) able to offer simpler and earlier diagnosis of endometriosis or the disease’s sub-categories
